Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Utilizing CGM and Wearable Device Data to Enhance Health Outcomes and Encourage Healthy Habits

Reading Time: 2 minutes

Continuous glucose monitoring (CGM) has revolutionized the way patients with diabetes manage their condition by providing real-time data on blood glucose levels and enabling them to make immediate lifestyle adjustments. This technology has not only improved the quality of life for millions of individuals but has also shown promising results in reducing mortality rates among diabetes patients.

During a session at the 2024 Heart in Diabetes Conference, renowned researchers Michael Snyder, PhD, and Peter Reaven, MD, shared their findings on the use of CGM for improving mortality in patients with diabetes. Snyder emphasized the increasing prevalence of wearable devices, with 20% to 25% of people in the US using some form of wearable technology. This trend has paved the way for more personalized and data-driven healthcare interventions.

Snyder’s research focused on using CGM data to identify metabolic subphenotypes, which are specific patterns in glucose curves that can predict individual responses to lifestyle changes. By analyzing the glucose curves of 36 individuals, researchers were able to establish guidelines for personalized lifestyle modifications based on CGM data. This approach allows for tailored interventions that can lead to better glucose control and overall health outcomes.

In addition to tracking blood glucose levels, wearable devices have made it easier to monitor overall metabolic data. Snyder demonstrated the versatility of wearable technology by wearing close to 7 different devices during his presentation. This integration of technology into everyday life has the potential to significantly impact mortality rates and promote healthier lifestyles.

Reaven’s research further supported the benefits of CGM in reducing mortality among patients with type 1 and type 2 diabetes. By analyzing data from over 10 million veterans, researchers found that the use of CGM was associated with a significant reduction in mortality compared to non-users. The study also highlighted other positive outcomes such as lower HbA1c levels, reduced episodes of hyper- or hypoglycemia, and fewer hospital admissions.

The findings presented by Snyder and Reaven underscore the importance of leveraging technology to improve healthcare outcomes for patients with diabetes. By utilizing CGM data and wearable devices, individuals and healthcare providers can work together to develop personalized treatment plans that address specific needs and promote long-term health.

As the field of wearable technology continues to evolve, the potential for improving mortality rates and enhancing quality of life for patients with diabetes is promising. The integration of CGM data and wearable devices represents a significant step forward in personalized healthcare and underscores the importance of leveraging technology to drive positive health outcomes.

Taylor Swifts New Album Release Health issues from using ACs Boston Marathon 2024 15 Practical Ways To Save Money